Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

Clinical trial NCT00005633 · COMPLETED

Trial details

NCT number: NCT00005633
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Melanoma (Skin)

Start date: 1999-06-01
Primary completion: 2002-06-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.